Laurus Labs Stock Scales New 52-Week Peak at Rs 2,034: Key Reasons Behind the Surge
- September 23, 2026
- Posted by: Harsh Piplani
- Category: News
Laurus Labs Share Price moved to Rs 2,032.40, up Rs 27.30 or 1.36% from the previous close of Rs 2,005.10, and it printed a fresh 52-week high at Rs 2,033.50. The company’s market capitalisation stood at Rs 1,09,035.01 crore, placing this move in a large, information-rich valuation context for Laurus Labs Ltd. (LAURUSLABS). The supplied data confirms the price event and shows the day’s range, turnover and valuation snapshot, but it does not establish a company-specific catalyst. For readers tracking Laurus Labs Share Price Today, the verified facts show the stock holding near its yearly high while the broader Laurus Labs Stock News narrative is being shaped by the price print, sector benchmarks and company fundamentals.
The move matters because Laurus Labs Share Price is now trading very close to the day’s peak, with the session low at Rs 2,001.85 and open at Rs 2,010. The data also points to a premium valuation against the pharmaceuticals peer set and the same-industry benchmark. Univest is following the print as a fresh 52-week high event, so investors looking at Laurus Labs Share Price Live can use the verified numbers below to understand what changed today and what to watch next.
Laurus Labs Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,032.4 |
| Previous Close | Rs 2,005.1 |
| Today's Move | +Rs 27.3 (+1.36%) |
| Open | Rs 2,010 |
| High | Rs 2,033.5 |
| Low | Rs 2,001.85 |
| Turnover | Rs 6.67 crore |
| Market Capitalisation | Rs 1,09,035.01 crore |
Laurus Labs Ltd. (LAURUSLABS) traded at Rs 2,032.4 versus the previous close of Rs 2,005.1, a rise of 1.36%. The stock opened at Rs 2,010, reached a high of Rs 2,033.5 and touched a low of Rs 2,001.85.
Laurus Labs Share Price Today was set by a move from Rs 2,005.10 to Rs 2,032.40, which equals a gain of Rs 27.30 or 1.36%. The stock opened at Rs 2,010, traded between Rs 2,001.85 and Rs 2,033.50, and ended at the same level as the fresh 52-week high. That gives the day a clean price-led news event for Laurus Labs Stock News, with the current quote sitting just below the peak by Rs 1.10.
Turnover stood at Rs 6.67 crore, which is the only trade-value metric supplied in the dataset. On the day, the price action shows that Laurus Labs Share Price has already crossed its one-year high mark for this cycle. For readers searching Laurus Labs Share Price Today, the verified record is straightforward: a fresh 52-week high, a positive close versus the previous day, and a narrow gap between the final price and the session high.
This is also why Univest is treating Laurus Labs Share Price as an event-led market update rather than a story about a disclosed trigger. The available data confirms the new yearly high, but does not provide a company-specific reason for the move.
Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,09,035.01 crore |
| P/E Ratio | 99.09x |
| P/B Ratio | 19.21x |
| ROE | 18.31% |
| ROCE | 18.2% |
| EPS | Rs 20.24 |
| Book Value Per Share | Rs 104.37 |
| Dividend Yield | 0.1% |
Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 99.09x, P/B 19.21x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.
Laurus Labs Ltd. has a market capitalisation of Rs 109035.01 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 99.09x, P/B at 19.21x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 99.09x |
| Benchmark Median P/E | 31.63x |
| Benchmark Average P/E | 49.25x |
| Benchmark P/E Range | 3.48x to 765.12x |
| Company P/B Ratio | 19.21x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 18.31% |
| Benchmark Median ROE | 11.69% |
| Company ROCE | 18.2% |
| Benchmark Median ROCE | 13.32% |
| Company Market Capitalisation | Rs 1,09,035.01 crore |
| Benchmark Median Market Cap | Rs 718.76 crore |
Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 99.09x, which is above the benchmark median of 31.63x, a difference of +213.28%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.69%, a difference of +56.63%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.32%, a difference of +36.64%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.1 | 3.17 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,860.07 | 25.66 | 4.3 | 19.69 | 21.39 |
| Mankind Pharma Ltd. | MANKIND | 1,00,363.76 | 50.14 | 6.09 | 12.69 | 13.24 |
| Dr. Reddy's Laboratories Ltd. | DRREDDY | 1,00,328.57 | 31.4 | 2.65 | 11.69 | 13.75 |
| Aurobindo Pharma Ltd. | AUROPHARMA | 98,803.89 | 26.3 | 2.51 | 9.93 | 12.76 |
Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 99.09x compared with the displayed peer median of 31.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,09,035.01 crore. Among the 5 peers shown, 2 have a larger market capitalisation.
Why Investors Are Watching Laurus Labs
- Laurus Labs Share Price touched Rs 2,033.50, which is the fresh 52-week high in the supplied data.
- The stock closed at Rs 2,032.40, above the previous close of Rs 2,005.10 by Rs 27.30.
- Market capitalisation stood at Rs 1,09,035.01 crore, placing Laurus Labs among the larger names in the peer set.
- P/E of 99.09 and P/B of 19.21 are both well above the same-industry medians supplied.
- ROE of 18.31% and ROCE of 18.2% are above the same-industry median levels in the dataset.
About Laurus Labs
Laurus Labs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile confirms the listed identity, sector classification and industry bucket used in this report. Laurus Labs Share Price is therefore being tracked within a pharmaceutical context that includes sector benchmarking, peer comparison and valuation analysis drawn only from the verified dataset. Univest is using the same data to connect Laurus Labs Stock News with market-cap, earnings and return metrics rather than speculation.
Track Laurus Labs Share Price on Univest
Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Laurus Labs Share Price on Univest for live share price updates, share price today context, company news, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest brings Laurus Labs Stock Analysis, Laurus Labs Fundamental Analysis and Laurus Labs Share Price Live information together in one place for quick review.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Laurus Labs Share Price hit a fresh 52-week high today?
Ans. The supplied data confirms that Laurus Labs Share Price reached Rs 2,033.50 and closed at Rs 2,032.40, but it does not establish a company-specific catalyst. The event is verified as a fresh 52-week high.
What is Laurus Labs Share Price today?
Ans. Laurus Labs Share Price today was Rs 2,032.40, up Rs 27.30 or 1.36% from the previous close of Rs 2,005.10. The stock also printed a fresh 52-week high at Rs 2,033.50.
What does Laurus Labs Share Price say about valuation?
Ans. Laurus Labs Share Price is supported by a P/E of 99.09 and a P/B of 19.21. Both are well above the same-industry medians supplied, which places the stock at a premium valuation.
How do Laurus Labs profitability ratios compare with the industry?
Ans. Laurus Labs has ROE of 18.31% and ROCE of 18.2%. Both are above the same-industry medians of 11.69% and 13.32%, giving the company stronger profitability readings than the benchmark median.
How does Laurus Labs Share Price compare with peers?
Ans. Laurus Labs Share Price carries a market capitalisation of Rs 1,09,035.01 crore, similar to Cipla and Zydus Lifesciences. Its P/E and P/B are much higher than the supplied peer set.
What should investors monitor next for Laurus Labs Share Price?
Ans. Investors can monitor whether Laurus Labs Share Price stays near the fresh 52-week high, how valuation compares with peers, and whether the next reported revenue and profit numbers continue the supplied trend.
